Issue 125 • December 2022 Inside the European mass shift to data-driven health solutions Chronic drug shortages signal difficult outlook for cardiovascular care ‘Twindemic’ risks warrant immediate steps in Europe and the US In association with What Rishi Sunak can do for the UK pharma industry Amidst a swap in UK leadership, the pharmaceutical industry hopes Rishi Sunak will free up funding and boost the economy In association with Issue 125 Brought to you by 11/23/2022 21:13:12